CorEvitas Alopecia Areata (AA) Safety and Effectiveness Registry

Description

Prospective, observational cohort study for subjects with AA under the care of a dermatology provider. Approximately 5,000 subjects and 100 clinical sites in North America will be recruited to participate with no defined upper limit for either target.

Conditions

Alopecia Areata

Talk to us

Study Overview

On this page

Study Details

Study overview

Prospective, observational cohort study for subjects with AA under the care of a dermatology provider. Approximately 5,000 subjects and 100 clinical sites in North America will be recruited to participate with no defined upper limit for either target.

CorEvitas Alopecia Areata (AA) Safety and Effectiveness Registry

CorEvitas Alopecia Areata (AA) Safety and Effectiveness Registry

Condition
Alopecia Areata
Intervention / Treatment

-

Contacts and Locations

Waltham

CorEvitas, LLC, Waltham, Massachusetts, United States, 02451

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * A subject must meet all the following criteria to participate in the registry:
  • 1. Has been diagnosed with alopecia areata by a dermatologist or a qualified dermatology practitioner.
  • 2. Is at least 18 years of age or older.
  • 3. Is willing to provide Personal Information.
  • 4. Is prescribed or starting an Enrollment Eligible Medication at the time of enrollment.
  • * Any of the following would exclude the subject from participating in the registry:
  • 1. Is participating or planning to participate in a double-blind randomized trial for an AA drug. Note:

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

CorEvitas,

Study Record Dates

2099-12-31